Concepedia

Suresh Solapure

SS

Statistics

Publications

20

Citations

1.4K

H-Index

16

Active since

1998

Affiliations

AstraZeneca (India)(Current)

AstraZeneca (United Kingdom)

AstraZeneca (United States)

TB Alliance

Medicines for Malaria Venture

Suresh Solapure is an author at AstraZeneca (India) specializing in pharmacology, enzyme inhibition, and drug discovery.

ORCID

Publications per year

1998–2018

20

Publications

20

Antimalarial efficacy of MMV390048, an inhibitor of <i>Plasmodium</i> phosphatidylinositol 4-kinase

Tanya Paquet, Claire Le Manach, Diego González Cabrera et al. · Science Translational Medicine · 2017 · 272 citations · Full text

, , +16

Azaindoles: Noncovalent DprE1 Inhibitors from Scaffold Morphing Efforts, Kill Mycobacterium tuberculosis and Are Efficacious <i>in Vivo</i>

Pravin S. Shirude, Radha Krishan Shandil, C Sadler et al. · Journal of Medicinal Chemistry · 2013 · 162 citations

, , +14

UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria

Christel Brunschwig, Nina Lawrence, Dale Taylor et al. · Antimicrobial Agents and Chemotherapy · 2018 · 136 citations · Full text

, , +17

Discovery of Imidazo[1,2-<i>a</i>]pyridine Ethers and Squaramides as Selective and Potent Inhibitors of Mycobacterial Adenosine Triphosphate (ATP) Synthesis

Subramanyam J. Tantry, Shankar D. Markad, Vikas Shinde et al. · Journal of Medicinal Chemistry · 2017 · 126 citations

, , +17

1,4-Azaindole, a Potential Drug Candidate for Treatment of Tuberculosis

Monalisa Chatterji, Radha Krishan Shandil, M. R. Manjunatha et al. · Antimicrobial Agents and Chemotherapy · 2014 · 109 citations · Full text

, , +15

1–5 of 20